# Study of Open Label Losartan in COVID-19

> **NCT04335123** · PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 34 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT04335123
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-04
- **Primary completion:** 2020-06-21
- **Final completion:** 2020-08-17
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04335123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04335123, "Study of Open Label Losartan in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04335123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*